Nuheara (ASX:NUH) - Cours de l'action, nouvelles et analyse

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

NUH Aperçu des actions

A wearables technology company, engages in the development and commercialization of hearing technology and products as regulated medical devices in Australia, the United States, and internationally.

A propos de l'entreprise

NUH analyse fondamentale
Score flocon de neige
Évaluation	0/6
Croissance future	0/6
Performances passées	0/6
Santé financière	3/6
Dividendes	0/6

Récompenses

Analyse des risques

Les revenus ont diminué de 11.8% par an au cours des 5 dernières années

Les actionnaires ont été considérablement dilués au cours de l'année écoulée

Les actions sont très illiquides

N'a pas de revenus significatifs ( A$2M )

+ 2 plus de risques

Nuheara Limited Concurrents

BirdDog Technology

ASX:BDT

AU$10.8m

Zimi

ASX:ZMM

AU$1.5m

Ambertech

ASX:AMO

AU$18.1m

Rubicon Water

ASX:RWL

AU$59.0m

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Nuheara
Historique des cours de bourse
Prix actuel de l'action	AU$0.081
Plus haut sur 52 semaines	AU$0.21
Plus bas sur 52 semaines	AU$0.07
Bêta	1.87
1Variation sur 1 mois	0%
Variation sur 3 mois	3.85%
Variation sur 1 an	-42.14%
3Variation sur 3 ans	-90.36%
Variation sur 5 ans	-94.53%
Évolution depuis l'introduction en bourse	-91.38%

Nouvelles et mises à jour récentes

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Oct 09

Recent updates

Rendement pour les actionnaires

	NUH	AU Tech	AU Marché
7D	0%	-0.5%	-0.7%
1Y	-42.1%	24.1%	17.1%

Rendement vs Industrie: NUH a sous-performé le secteur Australian Tech qui a rapporté 26.3 % au cours de l'année écoulée.

Rendement vs marché: NUH a sous-performé le marché Australian qui a rapporté 11.2 % au cours de l'année écoulée.

Volatilité des prix

Is NUH's price volatile compared to industry and market?
NUH volatility
NUH Average Weekly Movement	n/a
Tech Industry Average Movement	6.9%
Market Average Movement	8.9%
10% most volatile stocks in AU Market	17.6%
10% least volatile stocks in AU Market	3.7%

Cours de l'action stable: NUH n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: Données insuffisantes pour déterminer l'évolution de la volatilité de NUH au cours de l'année écoulée.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
n/a	n/a	Justin Miller	www.nuheara.com

Nuheara Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de Nuheara se comparent-ils à sa capitalisation boursière ?
NUH statistiques fondamentales
Capitalisation boursière	AU$21.76m
Bénéfices(TTM)	-AU$12.62m
Recettes(TTM)	AU$1.93m

11.3x

Ratio P/S

-1.7x

Ratio P/E

Le site NUH est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
NUH compte de résultat (TTM)
Recettes	AU$1.93m
Coût des recettes	AU$2.88m
Marge brute	-AU$951.47k
Autres dépenses	AU$11.67m
Les revenus	-AU$12.62m

Derniers bénéfices déclarés

Jun 30, 2023

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)	-0.047
Marge brute	-49.27%
Marge bénéficiaire nette	-653.33%
Ratio dettes/capitaux propres	46.3%

Quelles ont été les performances à long terme de NUH?

Voir les performances historiques et les comparaisons

NUH Aperçu des actions

Récompenses

Analyse des risques

Nuheara Limited Concurrents

ASX:BDT

AU$10.8m

ASX:ZMM

AU$1.5m

ASX:AMO

AU$18.1m

ASX:RWL

AU$59.0m

Historique des prix et performances

Nouvelles et mises à jour récentes

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Recent updates

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Nuheara Limited, Annual General Meeting, Nov 22, 2023

New major risk - Financial position

Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and Legal

New minor risk - Share price stability

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Insufficient new directors

Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing Aid

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.025401 million.

Nuheara Limited Receives US FDA Approval and Launches HP Hearing PRO

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Nuheara Limited Announces the Resignation of Jean-Marie Rudd as CFO

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Nuheara Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited Welcomes US Food and Drug Administration's Final Ruling, Establishing A Regulatory Category for Over-The-Counter (Otc) Hearing Aids in the United States

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Limited Announces Executive Changes

Nuheara Limited has filed an IPO in the amount of AUD 5 million.

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Submits 510(k) for U.S. FDA Clearance

Nuheara Announces Executive Changes

Nuheara Limited Announces Successful Clinical Trial Self-Fitted Hearing Aids

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Nuheara Clinical Trial and FDA 510(K) Pathway Update

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Nuheara Limited Provides Update on Clinical Trial and Pathway to FDA 510(K) Approval

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.011 loss in FY 2020)

Nuheara Limited Receives U.S. FDA Registration and Hearing Aid Device Listing

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in 1H 2020)

What Can We Make Of Nuheara's (ASX:NUH) CEO Compensation?

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 11.5 million.

Nuheara Limited announced that it expects to receive AUD 11.5 million in funding

Nuheara Limited Appoints Warwick Sauer as Director

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Nuheara Receives $2 Million Phase II Works with HP Inc

Full year earnings released - AU$0.011 loss per share

Nuheara Limited announced that it has received funding

Rendement pour les actionnaires

Volatilité des prix

À propos de l'entreprise

Nuheara Limited Résumé des fondamentaux

11.3x

-1.7x

Bénéfices et recettes